|
Q4 FY2026
As of Aug 31, 2026
|
Q3 FY2026
As of May 31, 2026
|
Q2 FY2026
As of Feb 28, 2026
|
|
|---|---|---|---|
| Cash | |||
| Prepaid expenses | |||
| Total Current Assets | |||
| Deferred offering costs | |||
| Investments held in Trust Account | |||
| Total Assets | |||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity | |||
| Accounts payable and accrued expenses | |||
| Promissory note - related party | |||
| Due to related party | |||
| Total Current Liabilities | |||
| Total Liabilities | |||
| Ordinary shares, $0.0001 par value; 600,000,000 shares authorized; 11,500,000 shares at redemption value of $10.15 per share and 0 shares subject to possible redemption as of August 31, 2026 and 2025, respectively | |||
| Shareholders’ (Deficit) Equity | |||
| Ordinary shares, $0.0001 par value; 600,000,000 shares authorized; 3,137,000 shares and 2,875,000 (1) issued and outstanding, respectively, as of August 31, 2026 and 2025 (excluding 11,500,000 and 0 shares subject to possible redemption as of August 31, 2026 and 2025, respectively) | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders' (Deficit) Equity | |||
| Total Shareholders’ (Deficit) Equity | |||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity |
Loading...